Avirup Guha: SDOH’s impact on hypertension control in cancer patients

Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared on X about a recent paper by Priyanshu Nain et al. titled “Adverse Social Determinants of Health Elevate Uncontrolled Hypertension Risk: A Cardio-Oncology Prospective Cohort Study” published in JNCI Cancer Spectrum.

Authors: Priyanshu Nain et al.

“New in Journal of the National Cancer Institute (JNCI) cancer spectrum: Social determinants of health (SDOH) strongly impact hypertension control in cancer patients. Our study found that high SDOH scores are linked to a 77% increased risk of uncontrolled HTN.”

Raul Cordoba shared this post, adding:

“Very relevant topic about CardioOnc to be covered by OncoDaily, International Cardio-Oncology Society and OncoAlert. Thanks to Avirup Guha for highlighting how social determinants of health may impact hypertension control in cancer patients.”

Source: Avirup Guha/X and Raul Cordoba/X

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation.

He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.